Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

A randomized parallel-group pilot study of a combination intervention using Motivational Interviewing (MI) and Contingency Management (CM) for patients with T2DM. Individuals will be randomized in a 1:1 ratio to the intervention group or the control group. Randomization will be blocked and stratified by long-acting insulin and GLP1 medication use. All participants will be given a Continuous Glucose Monitor (CGM) to assess real-time blood sugar levels and establish CM rewards for those assigned to the treatment group.

Inclusion criteria

• Diagnosed with type 2 diabetes
• Age 18 to 65
• Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months
• Most recent hemoglobin A1c result between 8.0 and 11.0
• Currently receiving treatment for diabetes by a licensed healthcare provider.
• Reliable access to a personal smart phone that is compatible with CGM
• English speaking

Exclusion criteria

• Type 1 diabetes
• Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease)
• Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan
• Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study
• Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)